Publication:
miR-7 Modulates hESC Differentiation into Insulin-Producing Beta-like Cells and Contributes to Cell Maturation.

dc.contributor.authorLopez-Beas, Javier
dc.contributor.authorCapilla-Gonzalez, Vivian
dc.contributor.authorAguilera, Yolanda
dc.contributor.authorMellado, Nuria
dc.contributor.authorLachaud, Christian C
dc.contributor.authorMartin, Franz
dc.contributor.authorSmani, Tarik
dc.contributor.authorSoria, Bernat
dc.contributor.authorHmadcha, Abdelkrim
dc.contributor.funderAndalusian Regional Ministry of Health
dc.contributor.funderSpanish Ministry of Economy, Industry and Competitiveness, Institute of Health Carlos III
dc.contributor.funderSpanish Ministry of Economy Industry and Competitiveness - FEDER Funds
dc.date.accessioned2023-01-25T10:21:58Z
dc.date.available2023-01-25T10:21:58Z
dc.date.issued2018-06-15
dc.description.abstractHuman pluripotent stem cells retain the extraordinary capacity to differentiate into pancreatic beta cells. For this particular lineage, more effort is still required to stress the importance of developing an efficient, reproducible, easy, and cost-effective differentiation protocol to obtain more mature, homogeneous, and functional insulin-secreting cells. In addition, microRNAs (miRNAs) have emerged as a class of small non-coding RNAs that regulate many cellular processes, including pancreatic differentiation. Some miRNAs are known to be preferentially expressed in islets. Of note, miR-375 and miR-7 are two of the most abundant pancreatic miRNAs, and they are necessary for proper pancreatic islet development. Here we provide new insight into specific miRNAs involved in pancreatic differentiation. We found that miR-7 is differentially expressed during the differentiation of human embryonic stem cells (hESCs) into a beta cell-like phenotype and that its modulation plays an important role in generating mature pancreatic beta cells. This strategy may be exploited to optimize the potential for in vitro differentiation of hESCs into insulin-producing beta-like cells for use in preclinical studies and future clinical applications as well as the prospective uses of miRNAs to improve this process.
dc.description.sponsorshipThis work was funded by grants from the Spanish Institute of Health Carlos III (PI16/00259, PI17/02104, and RD16/0011/0034), the Spanish Ministry of Economy Industry and Competitiveness (BFU2016-74932-C2 and BFU2013-45564-C2) co-financed by FEDER Funds , the Andalusian Regional Ministry of Health (PI-0272-2017), and ACTION Cost (European Cooperation in Science and Technology BM1305). CIBERDEM and CIBERCV are initiatives of the Institute of Health Carlos III. V.C.G. was the recipient of a Sara Borrell postdoctoral contract from the Spanish Ministry of Economy, Industry and Competitiveness, Institute of Health Carlos III (CD16/00118).
dc.description.versionSi
dc.identifier.citationLópez-Beas J, Capilla-González V, Aguilera Y, Mellado N, Lachaud CC, Martín F, et al. miR-7 Modulates hESC Differentiation into Insulin-Producing Beta-like Cells and Contributes to Cell Maturation. Mol Ther Nucleic Acids. 2018 Sep 7;12:463-477.
dc.identifier.doi10.1016/j.omtn.2018.06.002
dc.identifier.issn2162-2531
dc.identifier.pmcPMC6070677
dc.identifier.pmid30195784
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070677/pdf
dc.identifier.unpaywallURLhttp://www.cell.com/article/S216225311830129X/pdf
dc.identifier.urihttp://hdl.handle.net/10668/12924
dc.journal.titleMolecular therapy. Nucleic acids
dc.journal.titleabbreviationMol Ther Nucleic Acids
dc.language.isoen
dc.organizationCentro Andaluz de Biología Molecular y Medicina Regenerativa-CABIMER
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.organizationHospital Universitario Virgen del Rocío
dc.page.number463-477
dc.provenanceRealizada la curación de contenido 09/04/2025
dc.publisherCell Press
dc.pubmedtypeJournal Article
dc.relation.projectIDPI-0272-2017
dc.relation.projectIDCD16/00118
dc.relation.projectIDBFU2016-74932-C2
dc.relation.projectIDBFU2013-45564-C2
dc.relation.publisherversionhttps://linkinghub.elsevier.com/retrieve/pii/S2162-2531(18)30129-X
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectGene Ontology
dc.subjectHS181
dc.subjectKEGG
dc.subjectPdx-1
dc.subjectbeta cell
dc.subjectdifferentiation
dc.subjectendoderm
dc.subjecthESCs
dc.subjectinsulin
dc.subjectmaturation
dc.subjectmiR7
dc.subjectmicroRNA
dc.subjectpluripotent
dc.subject.decsCélulas
dc.subject.decsInsulina
dc.subject.decsCodificación clínica
dc.subject.decsIslotes pancreáticos
dc.subject.decsCélulas madre pluripotentes
dc.subject.decsPredicción
dc.subject.decsFenotipo
dc.subject.decsCognición
dc.subject.meshHumans
dc.subject.meshInsulin-Secreting Cells
dc.subject.meshHuman Embryonic Stem Cells
dc.subject.meshCost-Benefit Analysis
dc.subject.meshCell Differentiation
dc.subject.meshPluripotent Stem Cells
dc.subject.meshPhenotype
dc.titlemiR-7 Modulates hESC Differentiation into Insulin-Producing Beta-like Cells and Contributes to Cell Maturation.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number12
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
PMC6070677.pdf
Size:
3.55 MB
Format:
Adobe Portable Document Format
No Thumbnail Available
Name:
Lopez-Beas_miR-7Modulates _MaterialSuplementario.zip
Size:
3.57 MB
Format: